Singapore markets close in 1 hour 54 minutes

Emergent BioSolutions Inc. (EBS)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
57.47+0.32 (+0.56%)
At close: 4:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
1,708,700
1,555,400
1,106,000
782,400
560,873
Cost of revenue
644,400
524,000
433,500
322,300
195,707
Gross profit
1,064,300
1,031,400
672,500
460,100
365,166
Operating expenses
Research development
245,300
234,500
226,200
142,800
97,384
Selling general and administrative
329,700
303,300
273,500
202,500
143,497
Total operating expenses
635,000
597,600
558,400
370,300
240,881
Operating income or loss
429,300
433,800
114,100
89,800
124,285
Interest expense
33,400
31,300
38,400
9,900
6,590
Total other income/expenses net
-
4,700
1,700
1,600
-815
Income before tax
400,200
407,200
77,400
81,500
118,633
Income tax expense
101,000
102,100
22,900
18,800
36,039
Income from continuing operations
299,200
305,100
54,500
62,700
82,594
Net income
299,200
305,100
54,500
62,700
82,594
Net income available to common shareholders
299,200
305,100
54,500
62,700
82,594
Basic EPS
-
5.79
1.06
1.25
1.98
Diluted EPS
-
5.67
1.04
1.22
1.71
Basic average shares
-
52,700
51,500
50,100
41,816
Diluted average shares
-
53,800
52,400
51,400
50,328
EBITDA
-
553,000
226,500
153,600
167,795